Virogin Biotech

About:

Virogin Biotech is an antineoplastic drug developer.

Top Investors: Korea Investment Partners, Shenzhen Capital Group, CDH Investments, China Merchants Venture Capital, GP Capital

Description:

Virogin Biotech Ltd. ("Virogin") was founded in 2015, with the headquarters located in Vancouver, Canada. They are dedicated to developing the next generation of oncolytic virus (OV) therapeutics using their novel Synerlytic™ technical platform for improved cancer treatment. By exploring innovative approaches to immunotherapy, Virogin is committed to becoming a world leader in the field of immuno-oncology.

Total Funding Amount:

$204M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Vancouver, British Columbia, Canada

Founded Date:

2015-01-01

Contact Email:

contact(AT)virogin.com

Founders:

Chris Huang, William Jia

Number of Employees:

51-100

Last Funding Date:

2021-09-24

IPO Status:

Private

Industries: